Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Large Scale Spatial Risk and Comparative Prevalence of Borrelia miyamotoi and Borrelia burgdorferi Sensu Lato in Ixodes pacificus

  • Kerry Padgett ,

    Kerry.Padgett@cdph.ca.gov

    Affiliation California Department of Public Health, Vector-Borne Disease Section, Richmond, California, United States of America

  • Denise Bonilla,

    Affiliation California Department of Public Health, Vector-Borne Disease Section, Richmond, California, United States of America

  • Anne Kjemtrup,

    Affiliation California Department of Public Health, Vector-Borne Disease Section, Richmond, California, United States of America

  • Inger-Marie Vilcins,

    Current address: Texas Department of State Health Services, Emerging & Acute Infectious Disease Branch, Austin, Texas, United States of America

    Affiliation California Department of Public Health, Vector-Borne Disease Section, Richmond, California, United States of America

  • Melissa Hardstone Yoshimizu,

    Affiliation California Department of Public Health, Vector-Borne Disease Section, Richmond, California, United States of America

  • Lucia Hui,

    Current address: Alameda County Vector Control Services District, Alameda, California, United States of America

    Affiliation California Department of Public Health, Vector-Borne Disease Section, Richmond, California, United States of America

  • Milagros Sola,

    Affiliation Public Health Command Region-West, Joint Base Lewis-McChord, Washington, United States of America

  • Miguel Quintana,

    Affiliation Public Health Command Region-West, Joint Base Lewis-McChord, Washington, United States of America

  • Vicki Kramer

    Affiliation California Department of Public Health, Vector-Borne Disease Section, Richmond, California, United States of America

Abstract

Borrelia miyamotoi is a newly described emerging pathogen transmitted to people by Ixodes species ticks and found in temperate regions of North America, Europe, and Asia. There is limited understanding of large scale entomological risk patterns of B. miyamotoi and of Borreila burgdorferi sensu stricto (ss), the agent of Lyme disease, in western North America. In this study, B. miyamotoi, a relapsing fever spirochete, was detected in adult (n = 70) and nymphal (n = 36) Ixodes pacificus ticks collected from 24 of 48 California counties that were surveyed over a 13 year period. Statewide prevalence of B. burgdorferi sensu lato (sl), which includes B. burgdorferi ss, and B. miyamotoi were similar in adult I. pacificus (0.6% and 0.8%, respectively). In contrast, the prevalence of B. burgdorferi sl was almost 2.5 times higher than B. miyamotoi in nymphal I. pacificus (3.2% versus 1.4%). These results suggest similar risk of exposure to B. burgdorferi sl and B. miyamotoi from adult I. pacificus tick bites in California, but a higher risk of contracting B. burgdorferi sl than B. miyamotoi from nymphal tick bites. While regional risk of exposure to these two spirochetes varies, the highest risk for both species is found in north and central coastal California and the Sierra Nevada foothill region, and the lowest risk is in southern California; nevertheless, tick-bite avoidance measures should be implemented in all regions of California. This is the first study to comprehensively evaluate entomologic risk for B. miyamotoi and B. burgdorferi for both adult and nymphal I. pacificus, an important human biting tick in western North America.

Introduction

The relapsing fever spirochete, Borrelia miyamotoi, has recently been identified as a human pathogen in Russia, the Netherlands, Japan, and northeastern United States and is now considered an emerging infectious disease [1][6]. Borrelia miyamotoi was first identified in 1995 in Ixodes persulcatus ticks and blood from a Japanese field mouse (Apodemus argenteus) from the northern island of Japan [7]. Borrelia miyamotoi has since been detected in Ixodes tick species from other regions, including I. ricinus in Europe, I. scapularis in eastern North America [7][15], I. dentatus in mid-western North America [16], and I. pacificus in western North America [17][19]. Borrelia miyamotoi is one of three relapsing fever Borrelia species associated with ixodid ticks, along with B. lonestari [20] and B. theileri [21], [22]. Possible vertebrate reservoir hosts in North America include small rodents such as the white-footed mouse, deer, and ground dwelling birds such as wild turkeys [13], [16], [23], [24]. Unlike B. burgdorferi sensu stricto (ss), the agent of Lyme borreliosis, B. miyamotoi spirochetes can be maintained in ticks via transovarial and transtadial transmission and therefore do not necessarily require a vertebrate reservoir host to maintain the infection [8], [13], [25].

In both North America and Europe several members of the B. burgdorferi sensu lato complex, which includes B. burgdorferi ss, and B. miyamotoi have overlapping tick vectors and reservoir host species [13]. The prevalence of B. burgdorferi sensu lato (sl) in northwestern California I. pacificus nymphs averages 5%, [26] with prevalence locally as high as 20–40% [27], [28]. In southern California, the prevalence of B. burgdorferi sl in nymphal I. pacificus is much lower, generally less than 0.5% [29]. In a study conducted in the northeastern United States, B. burgdorferi ss was found to be 10 times more prevalent than B. miyamotoi in I. scapularis nymphs (20% versus 2%), and twice as prevalent in rodent reservoirs (12% versus 6%) [13]. In northern California (Mendocino County), the prevalence of B. miyamotoi in I. pacificus ticks has been detected at a prevalence similar to the Northeast in nymphs (1.7%) and slightly less in adults (0.7%) [18]. Ixodes pacificus is found throughout California, except in desert and high mountain regions. Like I. scapularis, I. ricinus, and I. persulcatus, I. pacificus adults and nymphs readily bite people.

Similar to other relapsing fever group spirochetes, B. miyamotoi is not easy to culture. Although the original isolates were cultured from tick and rodent blood [7], subsequent efforts to culture spirochetes from ticks or from human case patients have been unsuccessful in other regions of the world [14], [30]. For suspected human cases of tick-borne relapsing fever, detection by blood smear is the standard diagnostic technique [31]. Two human cases of B. miyamotoi were diagnosed by direct detection of spirochetes in cerebrospinal fluid and follow-up polymerase chain reaction (PCR) [3], [4]. All other human cases have been diagnosed based on molecular detection of B. miyamotoi DNA in acute whole blood from patients [1], [6].

Recent studies have linked previously considered “non-pathogenic” bacterial species or viruses initially described from ticks to human illness, including B. bissettii [32] and Rickettsia philipii [33] in California, R. parkeri in southeastern North America [34], and deer tick virus in eastern North America [35]. The clarification of emerging tick-borne pathogen ecology, especially in the context of comparison to what we know about B. burgdorferi sl, provides an important contextual basis from which public health response and messaging can benefit. As part of on-going tick surveillance for B. burgdorferi sl in California, testing for B. miyamotoi was added to the statewide tick testing program. This additional surveillance enhances our understanding of B. miyamotoi ecology by determining the geographic range and prevalence in California.

Materials and Methods

Tick collections

From 2000 through 2012, California Department of Public Health (CDPH) staff and partner agencies collected Ixodes pacificus adults and nymphs, primarily in recreational areas, such as forest service campgrounds, hiking trails or picnic areas in national, state, or regional parks. No permit is required for CDPH staff or staff working under CDPH supervision to collect ticks in California per the California Health and Safety Code 116110–116112. These studies did not involve any endangered or protected species. Ticks were collected from vegetation, leaf litter, or other substrate (e.g., logs, tree trunks, rocks), using 1-meter2 white double nap flannel “flag” attached to a 1.5-meter wooden dowel. Ticks were either maintained alive within 10#dram (37 mL) polystyrene containers (Fisher Scientific, USA) retained in sealed plastic bags with moistened paper toweling at 3°C (adults) or retained in 70% ethanol (subset of nymphs). In lieu of sampling a prescribed area, collectors typically flagged for a minimum of an hour and submitted at least 20 ticks per 779 collection events; many collections were opportunistic and most were at novel locations. These collections are posted on a California statewide interactive map: http://cdphgis.maps.arcgis.com/apps/SocialMedia/index.html?appid=8d99fb1135d1424f9d8a8711acb7d459.

Tick testing protocols

Ticks were tested by one of two protocols: A) pools of up to ten ticks were tested by PCR, using primers targeting generic Borrelia followed by B. burgdorferi specific primers or B) individually tested by using fluorescein-labeled antibody to detect Borrelia species spirochetes visually with positive ticks subjected to follow-up nested PCR testing with primers that differentiated between B. burgdorferi sl group and relapsing fever group Borrelia [36]. Both protocols are described in detail below.

From 2000 to 2009, ticks were tested in pools as follows. Live or frozen I. pacificus adults or nymphs were submitted to the US Army, Public Health Command Region–West, Washington for testing. Up to ten ticks of the same sex, stage, and collection site were placed in tubes for DNA extraction. Total DNA was extracted from the pooled ticks using the IsoQuick Nucleic (Orca) Acid Extraction kit (MicroProbe Corp, Bothell, WA, USA). Initially, a nested PCR protocol that targets the flagellin (fla) gene (GenBank Accession number: X69611) was used to screen samples; this protocol was Borrelia generic [37]. The PCR assays were performed using the illustra PuReTaq Ready-T-Go PCR Beads system (GE Healthcare Biosciences, Pittsburg, PA, USA) under the following conditions: 30 seconds at 95°C, 30 seconds at 55°C, and 1 minute at 75°C. Both external and internal nested PCR reactions were run for 40 cycles. Borrelia burgdorferi (B31) DNA isolated from culture was used as positive controls. Borrelia positive tick pools were further screened with one of two additional primer sets that were species-specific for B. burgdorferi sl spirochetes. These primers include sets developed to amplify a segment of the P66 gene [38] and species-specific flagellin primers [39] where positive results indicated B. burgdorferi sl infection. If negative for these B. burgdorferi sl-specific primers, a 614 bp partial flagellin gene sequence was compared to selected Borrelia sequences (e.g., B. miyamotoi) in Genbank (using Clustal X,1.81) to determine species. Results from this testing protocol are stated as minimum infection prevalence (MIP) per stage and by location: (Number of positive tick pools/number of total ticks tested) × 100.

Beginning in 2007 the tick testing protocol was modified to test live individual ticks. Ixodes pacificus were tested by CDPH Vector-Borne Disease Section laboratory using a direct fluorescent antibody assay (DFA) using fluorescein-labeled Borrelia generic antibodies (Kirkegaard & Perry Laboratories, Inc, Gaithersburg, MD, USA) as previously described [36], [40]. For those ticks with visible spirochetes detected by DFA, DNA was extracted from reserved frozen tissue using the DNeasy Blood and Tissue kit (Qiagen, Germantown, MD, USA) and a nested PCR was performed. The first reaction of the nested PCR targeted the 16S–23S rRNA intragenic spacer region was used to screen for the presence of Borrelia (1,336 bp) and was followed by a nested reaction that separated B. burgdorferi sl (970 bp) from B. miyamotoi (450 bp) [40]. Each PCR reaction mix included 5 µl of extracted tick DNA amplified in a 50 µl reaction mix containing 5 µM of each primer, 5 µl of 10X Thermopol Buffer (New England Biolabs, Ipswich, MA, USA), 1 µl dNTP solution (New England Biolabs, Ipswich, MA, USA), 0.25 µl Taq DNA polymerase (New England Biolabs, Ipswich, MA, USA) and autoclaved sterile Milli-Q water. For each reaction, a negative control of autoclaved Milli-Q water was used and a pure DNA isolate of B. burgdorferi ss strain B31 antigen was used as a positive control. PCR products were separated using the E-gel agarose gel electrophoresis system on pre-cast 2% gels stained with SYBR safe (Invitrogen, Carlsbad, CA, USA). Results from this testing protocol are expressed as prevalence: (the number of positive ticks/number of ticks tested) × 100. Starting in 2007, a subset of ticks were screened with DFA and positive samples tested by nested PCR; from 2010–2012 all ticks were tested with this protocol.

All ticks that tested positive for Borrelia species by either Borrelia-generic PCR or by DFA were then subsequently characterized by either comparative sequence analysis or by distinct gel sizes. All positive ticks were found to be either B. burgdorferi sl or B. miyamotoi (Figure 1). Since the initial focus of the study was to ascertain B. burgdorferi prevalence, a subset of ticks was tested only to Borrelia genus level after testing negative for B. burgdorferi sl. Ticks that tested positive for B. burgdorferi were not further tested to specific genomospecies and are considered B. burgdorferi sl.

thumbnail
Figure 1. Partial 16S–23S rRNA intragenic spacer region of Borrelia miyamotoi (450 bp) and B. burgdorferi sl (970 bp).

https://doi.org/10.1371/journal.pone.0110853.g001

Results

During 2000–2012, California Department of Public Health (CDPH) staff and partner agencies collected 24,635 adult and 3,252 nymphal I. pacificus from 47 counties in 779 separate collection events/sites (Table S1). From 2000 to 2009, the following I. pacificus were tested in pools of up to 10 ticks per pool: 18,599 adults in 2,184 pools and 1,064 nymphs in 110 pools from 34 counties (Table 1). Of the pooled ticks tested with the first protocol using PCR with flagellin primers, 108 pools of the adult I. pacificus were positive for Borrelia spirochetes (0.6% minimum infection prevalence (MIP); n = 2,184 pools of 18,599 ticks). Of these positive pools, 61 pools (0.3% MIP) were positive for B. burgdorferi sl and 19 (0.1% MIP) were positive for B. miyamotoi. Although the remaining 28 pools were not positive for B. burgdorferi sl, they were not sequenced due to lack of material. Of the 1,064 nymphal I. pacificus tested in 110 pools, 15 (1.4% MIP) of these pools were positive for Borrelia spirochetes. Borrelia burgdorferi sl was detected in 9 nymphal tick pools (0.9% MIP) and B. miyamotoi in 6 pools (0.6% MIP).

thumbnail
Table 1. California Ixodes pacificus adult and nymphal ticks, tested in pools or tested individually, 2000–2012.

https://doi.org/10.1371/journal.pone.0110853.t001

The non-B. burgdorferi sl positive ticks were sequenced for the partial flagellin gene (614 bp) and BLAST analysis indicated that they most closely aligned with B. miyamotoi (96.9%) (GenBank accession number: AY024344.1) and more distantly with B. lonestari (91.0%). The non-B. burgdorferi sl positive ticks were also found to be more distantly aligned with B. burgdorferi sl (86.4%), B. garinii (86.5%) and B. afzelii (82.2%).

The prevalence as calculated with the individual tick-testing approach, provided higher prevalence estimates compared to the minimum infection prevalence pool testing approach. Beginning in 2007, the tick testing protocol was modified to test individual ticks. Ixodes pacificus (6,036 adults and 2,188 nymphs) from 38 counties were tested individually (Table 1), screened first by DFA, with Borrelia positives further characterized by nested PCR. Parallel to results of ticks tested in pools, B. burgdorferi sl and B. miyamotoi had similar prevalence in adult ticks with 37 individual ticks (0.6%) positive for B. burgdorferi sl and 51 (0.8%) positive for B. miyamotoi. Interestingly, nymphal I. pacificus infection prevalence was 2.5 times higher for B. burgdorferi sl (3.2%) than for B. miyamotoi (1.4%) (Table 2). A single nymph from Marin County tested positive for both B. burgdorferi sl and B. miyamotoi. While both DFA and nestedPCR are sensitive assays for detection of Borrelia, the inherent limitation of all diagnostic pathogen detection methods underestimate infection prevalence.

thumbnail
Table 2. Proportion of individual adult and nymphal Ixodes pacificus ticks with Borrelia burgdorferi sensu lato and B. miyamotoi detected in California, 2009–2012.

https://doi.org/10.1371/journal.pone.0110853.t002

While B. burgdorferi sl and B. miyamotoi were detected in I. pacificus in those regions of California where this tick species is abundant, there is variation in overall prevalence of both agents (Figure 2). Borrelia burgdorferi sl was more prevalent in northern and central coastal California and in the Sierra Nevada foothills: the highest MIP for B. burgdorferi sl in adult ticks was reported from Napa (4.04), Mariposa (3.57), Santa Clara (3.12), San Luis Obispo (1.74), and Tuolumne (1.5) counties. The highest prevalence was found in Placer (10.0), El Dorado (3.2), Nevada (2.12), San Mateo (1.58), and Santa Clara (1.2) counties (Figure 3). Similarly, B. miyamotoi was also highly prevalent in northern and coastal regions as well as the Sierra foothills: the highest B. miyamotoi MIP of adults was recorded in Monterey (1.1), Nevada (0.92), Santa Cruz (0.47), Lake (0.44) and Sonoma (0.22) counties and highest prevalence of B. miyamotoi in adults was recorded in San Mateo (6.33), Siskiyou (6.25), Lake (1.78), Butte (1.72), and Solano counties (1.41) (Figure 4).

thumbnail
Figure 2. Borrelia burgdorferi sl and/or B. miyamotoi detected by California counties, 2000–2012.

https://doi.org/10.1371/journal.pone.0110853.g002

thumbnail
Figure 3. Adult and nymphal B. burgdorferi sl pooled results (minimum infection prevalence) and individual tick results (prevalence), 2000–2012.

https://doi.org/10.1371/journal.pone.0110853.g003

thumbnail
Figure 4. Adult and nymphal B. miyamotoi pooled results (minimum infection prevalence) and individual tick results (prevalence), 2000–2012.

https://doi.org/10.1371/journal.pone.0110853.g004

Few B. burgdorferi sl and B. miyamotoi positive ticks were detected in southern California during this study. Despite testing over 5,000 adult ticks from Los Angeles County, only one B. burgdorferi sl positive tick was detected from Catalina Island. Similarly, Riverside County had no B. burgdorferi sl infected ticks detected and only two positive for B. miyamotoi despite over 1,600 adult ticks tested.

Similar to adult ticks, B. burgdorferi sl in nymphs was more commonly detected in northern California and Sierra foothill counties with the highest recorded B. burgdorferi sl prevalences in nymphal I. pacificus from Placer (10.0), Nevada (2.13), Butte (1.72), San Mateo (1.58), and Santa Clara (1.2) counties. For B. miyamotoi, the counties with the highest prevalence in nymphs were Nevada (6.84), Amador (4.85), Placer (2.56), San Mateo (2.56) and El Dorado (2.44) counties. All nymphal ticks were tested individually (prevalence results only). No nymphal I. pacificus tested positive for B. burgdorferi sl or B. miyamotoi from southern California, a region where collection of this stage is difficult.

Discussion

This 13-year comparative study documents both B. burgdorferi sl and B. miyamotoi prevalences in I. pacificus ticks over a large geographic region and denotes the potential relative risk of contracting these two Borrelia human pathogens from nymphal and adult tick bites. These data suggest a similar risk of exposure to B. miyamotoi as to B. burgdorferi sl from adult ticks in western North America. Moreover, there is a higher risk of acquiring B. burgdorferi sl than B. miyamotoi from nymphal ticks. Both B. burgdorferi sl and B. miyamotoi are found in many regions of California but are most abundant in the north coastal and foothill regions of the state. This is the first study to provide a comprehensive estimate of entomologic risk for B. burgdorferi sl and B. miyamotoi over a large region of western North America as most studies have focused on only the region of California considered to be endemic for Lyme disease (north-western portion of state).

Borrelia miyamotoi is now recognized as a human pathogen in Europe and the eastern United States. One of the primary objectives for this study was to assess B. miyamotoi prevalence in I. pacificus nymphs and adults, the two stages of ticks that commonly bite people in western North America. Soon after being described in ticks in the eastern United States [8], CDPH-VBDS detected B. miyamotoi in California in pools of adult I. pacificus collected in 2000 from Sonoma, Monterey, and San Luis Obispo counties [17]. It was subsequently detected in I. pacificus collected in Mendocino County [18] and more recently in San Mateo and Santa Clara counties [19]. While B. miyamotoi has been detected in the white-footed mouse, deer, and wild turkeys in other parts of North America, this spirochete has not been detected in potential vertebrate reservoirs in California – future research is needed to understand the transmission ecology of B. miyamotoi in California.

In North America, seven genomospecies have been identified within the B. burgdorferi sl complex, including B. burgdorferi ss, B. americana, B. andersoni, B. bissettii, B. californiensis, B. carolinensis, B. kurtenbachii, and B. garinii [42][47]. The life-cycles of these Borrelia species are complex and involve members of the hard tick genus Ixodes and numerous vertebrate reservoirs [48]. To date, only B. burgdorferi ss, B. americana, B. bissettii, and B. californiensis have been described in I. pacificus from California, along with various uncharacterized Borrelia species [29], [42], [43].

Lyme borreliosis is the most commonly reported vector-borne disease in North America [49]. Thus far, a total of 18 Borrelia genomospecies have been described in Ixodid ticks worldwide [50], with the causative agent of Lyme borreliosis being designated as B. burgdorferi ss and other closely related species composing the B. burgdorferi sl complex. In the western United States, I. pacificus is the only tick species that transmits B. burgdorferi ss to humans, and the nymphal stage is the primary vector [51]. Ixodes pacificus is widely distributed in the far west from southern British Columbia to northwestern Baja California and as far east as Utah [52]. In California, I. pacificus has been recorded in 56 of 58 counties (CDPH unpublished results).

Borrelia miyamotoi belongs in the relapsing fever group, a separate clade from B. burgdorferi sl [30]. While relapsing fever group Borrelia are predominately associated with argasid ticks (soft ticks) such as Ornithodoros species, B. miyamotoi is the only relapsing fever group spirochete associated with ticks in the Ixodes ricinus species complex. In California, B. hermsii is the most commonly reported relapsing fever group pathogen, with an average of eight human cases reported per year [17]. This agent is transmitted to people by soft ticks, Ornithodoros hermsi, typically in rodent-infested mountainous cabins. Other relapsing fever group Borrelia species in California include: B. parkeri, transmitted by O. parkeri, primarily in California’s Central Valley, B. turicatae, transmitted by O. turicatae, and B. coreaceae, transmitted by O. coriaceus. Other than a handful of cases of B. parkeri in the Central Valley in the early 1900 s [53], none of the later species are typically associated with human infection in California.

The distribution of B. miyamotoi in California appears to mirror the range of I. pacificus and similar to B. burgdorferi sl, it is most prevalent in north-coastal and foothill regions of California where ticks are associated with hardwood conifer woodland habitats [26], [54]. In most counties in northern California, and often within the same collection sites, both B. burgdorferi sl and B. miyamotoi were detected. Results from this study suggest that although B. miyamotoi is detected in I. pacificus from diverse regions of California, both B. miyamotoi and B. burgdorferi sl have lowest prevalence in southern California. This may parallel the findings of a lower density of infected nymphs (DIN) in south-eastern North America and thus a lower risk of exposure to Lyme disease [55]. A recent study of over 2,000 adult I. pacificus in Los Angeles County found a similar low prevalence of B. burgdorferi sl, with only 0.04% I. pacificus positive for the human pathogen, B. burgdorferi ss [29]. Nymphal ticks are difficult to collect in southern California, likely due to environmental conditions, and thus few nymphs were tested from southern California in this study as well as in previous studies [29].

In this study, ticks were tested both in pools as well as individually. When infection prevalences are low, e.g., 1–5%, expected results for both approaches would be comparable. Here, the individual testing approach yielded a higher prevalence of Borrelia spp. in ticks than those tested in pools. This result may not necessarily be reflective of testing ticks in pools but could be because a higher proportion of ticks post-2007, when more ticks were tested individually, were from northern and foothill regions, as compared to southern California.

Unlike B. burgdorferi ss, which is not transmitted from infected adult female to eggs, B. miyamotoi is transovarially transmitted, thus larval ticks may be infected [8], [13], [25]. Furthermore, ixodid ticks can be considered a reservoir for this agent and B. miyamotoi does not need to rely on vertebrate reservoir hosts to maintain local infection prevalence. Previously reported Borrelia positive I. scapularis, I. pacificus, and I. ricinus larvae, detected by direct or indirect fluorescence antibody tests, were most likely detections of B. miyamotoi [25]. DFA-positive larvae from field-collected female I. pacificus, previously attributed to B. burgdorferi, were likely infected with B. miyamotoi [25], [56]. Furthermore, B. miyamotoi is difficult to culture and Borrelia obtained from larval ticks have been uncultivable [56]. Additional transmission studies with B. burgdorferi-infected laboratory I. pacificus colonies showed no evidence of transovarial transmission [25], [57]. While the infection of larvae with B. miyamotoi suggests human risk from larval tick bites, I. pacificus larvae are rarely reported as an ectoparasite of people (CDPH, unpublished results) [58].

With improved molecular detection methods, there is interest in cataloging the bacterial and viral communities within ticks and other biting arthropods, as some of these may be potential human pathogens [48], [59]. Out of approximately 800 adult I. pacificus from seven northern California counties, tested with 18 primer pairs in a combined PCR with electrospray ionization mass spectrometry (Ibis Biosciences), the prevalence of B. burgdorferi sl and B. miyamotoi was found to be similar to this study; in addition, Rickettsia and Anaplasma were detected among other bacteria and endosymbionts (Crowder, C and Eshoo, M, personal communication). Similarly, with increasing use of multiplex assays, there is interest and capabilities to detect co-infections in ticks. Ixodes scapularis adult ticks have been found to harbor co-infections of B. burgdorferi sl and B. miyamotoi in New York state and Canada [60], [61]. In our study, only one nymph from Marin County tested positive for both B. burgdorferi sl and B. miyamotoi.

Although B. burgdorferi sl group spirochetes were not further characterized to genomospecies here, it is likely that many positive ticks from California may harbor B. bissettii, B. americana, B. andersonii, or B. californiensis in addition to B. burgdorferi ss [45]. The diversity of Borrelia species in California I. pacificus should be taken into account when testing ticks for B. burgdorferi sl for surveillance purposes; if testing methods are not specific enough, the prevalence of B. burgdorferi ss in a tick population may be overestimated. Furthermore, additional analyses regarding the genomospecies should be taken into account to help elucidate the complex vector-reservoir-Borrelia strain ecology in California.

In California, 0.8% of adult and 1.4% of nymphal I. pacificus were infected with B. miyamotoi, suggesting similarly low risk of exposure to this spirochete for each stage. This is similar to surveillance results in Europe where the prevalence in adult and nymphal ticks collected in Estonia was estimated at 0.8% and 1%, respectively [15]. In comparison, the risk of acquiring B. burgdorferi ss is higher following a nymphal versus adult I. pacificus bite in California [49]. As determined by this study, statewide estimates of B. burgdorferi sl infection of 3.3% in nymphs and 0.7% in adults support this higher risk. Results presented here suggest comparable risk of transmission for B. burgdorferi sl and B. miyamotoi following an adult I. pacificus bite; however, the risk of exposure is 2.5 times higher for B. burgdorferi sl than for B. miyamotoi following a nymphal I. pacificus bite in California. Although this study includes a large sample size of ticks over a large geographic region, sampling was not conducted using methods such as a grid to facilitate calculation of index of risk such as density of infected nymphs (DIN) [55]. Thus, it should be noted that relative prevalences of these Borrelia may differ locally and temporally.

Laboratories that test ticks removed from humans or test ticks as part of a regional risk assessment program in western North America should ensure that their tests are specific for B. burgdorferi ss so as to not inflate risk estimates for Lyme borreliosis. Furthermore, due to the increased interest in diverse potentially pathogenic Borrelia species, including those within the B. burgdorferi sl group, more specific characterization may also prove to be informative when describing human risk for emerging tick-borne pathogens. With the knowledge that B. miyamotoi is present in California ticks, at a comparable prevalence to other parts of the world where human cases of B. miyamotoi have been reported, physicians should keep tick-borne relapsing fever as part of their differential diagnosis when evaluating patients with compatible disease following an I. pacificus bite and if suspected, contact their infectious disease specialist or local health officer for guidance in testing. Furthermore, these results highlight the continuing need for the general public to be familiar with tick bite prevention measures to avoid exposure to the diverse pathogens ticks carry.

Supporting Information

Table S1.

Collection Locations for Ixodes pacificus.

https://doi.org/10.1371/journal.pone.0110853.s001

(XLSX)

Acknowledgments

We acknowledge all CDPH staff and California vector control agency staff who collected ticks as part of this surveillance program, including Martin Castro, Michael Niemela, Mark Novak, Jonathan Kwan, Joshua Ogawa, Lawrence Bronson, Peter Bonkrude, James Tucker, Tina Feiszli, Robin Spano, Barry Hess, Anne Donohue, and Bonnie Ryan. In addition, many thanks to all CDPH employees who conducted laboratory analyses: Ian Rose, Tina Feiszli, Rachel Bouttenot, William Thompson, and Robert Payne. Special thanks to Mary Joyce Pakingan who spent years carefully looking at spirochetes under the microscope.

Author Contributions

Conceived and designed the experiments: KP MQ VK. Performed the experiments: MS KP IV MY. Analyzed the data: KP DB AK MQ. Contributed reagents/materials/analysis tools: LH DB MS MQ. Contributed to the writing of the manuscript: KP MY DB.

References

  1. 1. Platonov AE, Karan LS, Kolyasnikova NM, Makhneva NA, Toporkova MG, et al. (2011) Humans infected with relapsing fever Borrelia miyamotoi, Russia. Emerg Infect Dis 17: 1816–1823.
  2. 2. Krause PJ, Narasimhan S, Worsmer GP, Rollend L, Fikrig E (2013) Human Borrelia miyamotoi infection in the United States. N Engl J Med 368: 291–293.
  3. 3. Gugliotta JL, Goethert HK, Berardi VP, Telford SR (2013) Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient. N Engl J Med 368: 240–245.
  4. 4. Houvius JWR, de Wever B, Sohne MC, Brouwer MC, Coumou J, et al. (2013) A case of meningoencephalitis by the relapsing fever spirochete Borrelia miyamotoi in Europe. Lancet 382: 658.
  5. 5. Sato K, Takano A, Konnai S, Nakao M, Ito T, et al. (2014) Human infections with Borrelia miyamotoi, Japan. Emerg Infect Dis 20: 1391–1393.
  6. 6. Chowdri HR, Gugliotta JL, Berardi VP, Goethert HK, Molloy PJ, et al. (2013) Borrelia miyamotoi infection presenting as human granuolocytic anaplasmosis. Ann Intern Med 159: 21–27.
  7. 7. Fukunaga M, Takahashi Y, Tsuruta Y, Matsushita O, Ralph D, et al. (1995) Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan. Int J Syst Bacteriol 45: 804–810.
  8. 8. Scoles GA, Papero M, Beati L, Fish D (2001) A relapsing fever group spirochete transmitted by Ixodes scapularis ticks. Vector Borne Zoonot Dis 1: 21–34.
  9. 9. Fraenkel CJ, Garpmo U, Berglund J (2002) Determination of novel Borrelia genospecies in Swedish Ixodes ricinus ticks. J Clin Microbiol 40: 3308–3312.
  10. 10. Richter D, Schlee DB, Matuschka FR (2003) Relapsing fever–like spirochetes infecting European vector tick of Lyme disease agent. Emerg Infect Dis 9: 697–701.
  11. 11. Bunikis J, Tsao J, Garpmo U, Berglund J, Fish D, et al. (2004) Typing of Borrelia relapsing fever strains. Emerg Infect Dis 10: 1661–1664.
  12. 12. Ullmann AJ, Gabitzsch ES, Schulze TL, Zeidner NS, Piesman J (2005) Three multiplex assays for detection of Borrelia burgdorferi sensu lato and Borrelia miyamotoi sensu lato in field-collected Ixodes nymphs in North America. J Med Entomol 42: 1057–1062.
  13. 13. Barbour AG, Bunikis J, Travinksy B, Hoen AG, Diuk-Wasser MA, et al. (2009) Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian species. Am J Trop Med Hyg 81: 1120–1131.
  14. 14. Fomenko NV, Livanova NN, Borgoyakov VY, Kozlova IV, Shulaykina IV, et al. (2010) Detection of Borrelia miyamotoi in Ixodes persulcatus ticks in Russia. Entomol Rev 90: 1088–1094.
  15. 15. Geller J, Nazarova L, Katargina O, Jarvekulg L, Fomenko N, et al. (2012) Detection and genetic characterization of relapsing fever spirochete Borrelia miyamotoi in Estonian ticks. PLoS One 7: e51914.
  16. 16. Hamer SA, Hickling GJ, Keith R, Sidge JL, Walker ED, et al. (2012) Associations of passerine birds, rabbits, and ticks with Borrelia miyamotoi and Borrelia andersonii in Michigan, U.S.A. Parasites & Vectors. 5: 231–242.
  17. 17. CDPH-VBDS Annual Report 2001. http://www.cdph.ca.gov/programs/vbds/Documents/VBDSAnnualReport02.pdf.
  18. 18. Mun J, Eisen RJ, Eisen L, Lane RS (2006) Detection of a Borrelia miyamotoi sensu lato relapsing-fever group spirochete from Ixodes pacificus in California. J Med Entomol 43: 120–123.
  19. 19. Salkeld DJ, Cinkovich S, Nieto NC (2014) Tick-borne pathogens in northwestern California, USA. Emerg Infect Dis 20: 493–494.
  20. 20. Varela-Stokes AS (2007) Transmission of bacterial agents from lone star ticks to white-tailed deer. J Med Entomol 44: 478–483.
  21. 21. Barbour AG (2001) Borrelia: a diverse and ubiquitous genus of tick-borne pathogens. In: Scheld WM, Craig WA, Hughes JM, editors. Emerging Infections 5. Washington DC: American Society for Microbiology Press. Pp. 153–174.
  22. 22. Rich SM, Armstrong PM, Smith RD, Telford SR (2001) Lone star tick-infecting borreliae are most closely related to the agent of bovine borreliosis. J Clin Microbiol 39: 494–497.
  23. 23. Scott JD, Lee MK, Fernando K, Durden LA, et al. (2010) Detection of Lyme disease spirochete, Borrelia burgdorferi sensu lato, including three novel genotypes in ticks (Acari: Ixodidae) collected from songbirds (Passeriformes) across Canada. J Vector Ecol 35: 124–139.
  24. 24. Rosen ME, Hamer SA, Gerhardt RR, Jones CJ, Muller LI, et al. (2012) Borrelia burgdorferi not detected in widespread Ixodes scapularis (Acari: Ixodidae) collected from white tailed-deer in Tennessee. J Med Entomol 49: 1473–1480.
  25. 25. Rollend L, Fish D, Childs JE (2012) Transovarial transmission of Borrelia spirochetes by Ixodes scapularis: A summary of the literature and recent observations. Ticks Tick-borne Dis 4: 46–51.
  26. 26. Eisen RJ, Eisen L, Girard YA, Federova N, Mun J, et al. (2010) A spatially-explicit model of acarological risk of exposure to Borrelia burgdorferi-infected Ixodes pacificus nymphs in northwestern California based on woodland type, temperature and water vapor. Ticks Tick-borne Dis 1: 35–43.
  27. 27. Tälleklint-Eisen L, Lane RS (1999) Variation in the density of questing Ixodes pacificus (Acari: Ixodidae) nymphs infected with Borrelia burgdorferi at different spatial scales in California. J Parasitol 85: 824–831.
  28. 28. Swei A, Meentemeyer M, Briggs CJ (2011) Influence of abiotic and environmental factors on the density and infection prevalence of Ixodes pacificus (Acari: Ixodidae) with Borrelia burgdorferi. J Med Entomol 48: 20–28.
  29. 29. Lane RS, Fedorova N, Kleinjan JE, Maxwell M (2013) Eco-epidemiological factors contributing to the low risk of human exposure to ixodid tick-borne borreliae in southern California, USA. Ticks Tick-Borne Dis 4: 377–85.
  30. 30. Hue F, Ghalyanchi Langeroudi A, Barbour AG (2013) Chromosome sequence of Borrelia miyamotoi, an uncultivable tick-borne agent of human infection. Genome Announcements 1: e00713–13.
  31. 31. Dworkin MS, Schwan TG, Anderson DE, Borchardt SM (2008) Tick-borne relapsing fever. Infect Dis Clin North Am 22: 449-viii.
  32. 32. Girard YA, Federova N, Lane RS (2011) Genetic diversity of Borrelia burgdorferi and detection of B. bissettii-like DNA in serum of north-coastal California residents. J Clin Microbiol 49: 945–954.
  33. 33. Shapiro MR, Fritz CL, Tait K, Paddock CD, Nicholson WL, et al. (2010) Rickettsia 364D: A newly recognized cause of eschar-associated illness in California. Clin Infect Dis. 50: 541–548.
  34. 34. Paddock CD, Finley RW, Wright CS, Robinson HN, Schrodt BJ, et al. (2008) Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin Infect Dis 47: 1188–1196.
  35. 35. Kuno G, Artsob H, Karabatsos N, Tsuchiya KR, Chang GJ (2001) Genomic sequencing of deer tick virus and phylogeny of Powassan-related viruses of North America. Am J Trop Med Hyg 6: 671–676.
  36. 36. Padgett KA, Bonilla DL (2011) Novel exposure sites for nymphal Ixodes pacificus within picnic areas. Ticks Tick-borne Dis 2: 191–195.
  37. 37. Barbour AG, Maupin GO, Teltow GJ, Carter CJ, Piesman J (1996) Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness. J Infect Dis 173: 403–409.
  38. 38. Rosa PA, Hogan D, Schwan TG (1991) Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi. J Clin Microbiol 29: 524–532.
  39. 39. Johnson BJB, Happ CM, Mayer LW, Piesman J (1992) Detection of Borrelia burgdorferi in ticks by species specific amplication of the flagellin gene. Am J Trop Med Hyg 47: 730–741.
  40. 40. Persing DH, Telford SR 3rd, Spielman A, Barthold SW (1990) Detection of Borrelia burgdorferi infection in Ixodes dammini ticks with the polymerase chain reaction. J Clin Microbiol 28: 566–572.
  41. 41. Travinksy B, Bunikis J, Barbour AG (2010) Geographic differences in genetic linkages for Borrelia burgdorferi. Emerg Infect Dis 16: 1147–1150.
  42. 42. Rudenko N, Golovchenko M, Lin T, Gao L, Grubhoffer L, et al. (2009) Delineation of a new species of the Borrelia burgdorferi sensu lato complex, Borrelia americana sp. nov. J Clin Microbiol 47: 3875–3880.
  43. 43. Postic D, Garnier M, Baranton G (2007) Multilocus sequence analysis of atypical Borrelia burgdorferi sensu lato isolates – Description of Borrelia californiensis sp. nov., and genomospecies 1 and 2. Int J Med Microbiol 297: 263–271.
  44. 44. Postic D, Marti Ras N, Lane RS, Hendson M, Baranton G (1998) Expanded diversity among Californian Borrelia isolates and description of Borrelia bissettii sp. nov. (Formerly Borrelia Group DN127).. J Clin Microbiol 36: 3497–3504.
  45. 45. Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH (2011) Borrelia carolinensis sp. nov., a new species of Borrelia burgdorferi sensu lato isolated from rodents and ticks from the southwestern United States. Int J Syst Evol Microbiol 31: 381–383.
  46. 46. Margos G, Hojgaard A, Lane RS, Cornet M, Fingerle V, et al. (2010) Multilocus sequence analysis of Borrelia bissettii strains from North America reveals a new Borrelia species, Borrelia kurtenbachii. Ticks Tick-Borne Dis 1: 151–158.
  47. 47. Smith RP, Bin Muzaffar S, Lavers J, Lacombe EH, Cahill BK, et al. (2006) Borrelia garinii in seabird ticks (Ixodes uriae), Atlantic Coast, North America. Emerg Infect Dis 12: 1909–1912.
  48. 48. Kurtenbach K, Hanincova K, Tsao JL, Margos G, Fish D, et al. (2006) Fundamental processes in the evolutionary ecology of Lyme borreliosis. Nat Rev Microbiol 4: 660–669.
  49. 49. Bacon RM, Kugeler MJ, Mead PS (2008) Surveillance for Lyme disease – United States, 1992–2006. Morb Mort Wkly Rep Surveill Summ 57: 1–9.
  50. 50. Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH (2011) Updates on Borrelia burgdorferi sensu lato complex with respect to public health. Ticks Tick-Borne Dis 2: 123–128.
  51. 51. Clover JR, Lane RS (1995) Evidence implicating nymphal Ixodes pacificus (Acari: Ixodidae) in the epidemiology of Lyme disease in California. Am J Trop Med Hyg 53: 237–240.
  52. 52. Kain DE, Sperling FAH, Daly HV, Lane RS (1999) Mitochondrial DNA sequence variation in Ixodes pacificus (Acari: Ixodidae). Heredity 83: 378–386.
  53. 53. Beck MD (1942) Present distribution of relapsing fever in California. In: Moulton FR, editor. A Symposium on Relapsing Fever in the Americas. Washington DC: American Association for the Advancement of Science, 20–25.
  54. 54. Eisen RJ, Eisen L, Castro MB, Lane RS (2003) Environmentally related variability in risk of exposure to Lyme disease spirochetes in northern California: Effect of climatic conditions and habitat type. Environ Entomol 32: 1010–1018.
  55. 55. Diuk-Wasser MA, Gatewood Hoen A, Cislo P, Brinkerhoff R, Hamer SA, et al. (2012) Human risk of infection with Borrelia burgdorferi, the Lyme disease agent, in eastern United States. Am J Trop Med Hyg 86: 320–327.
  56. 56. Lane RS, Burgdorfer W (1987) Transovarial and transstadial passage of Borrelia burgdorferi in the western black-legged tick, Ixodes pacificus (Acari: Ixodidae). Am J Trop Med Hyg 37: 188–192.
  57. 57. Schoeler GB, Lane RS (1993) Efficiency of transovarial transmission of the Lyme disease spirochete, Borrelia burgdorferi, in the western blacklegged tick, Ixodes pacificus (Acari: Ixodidae). J Med Entomol 30: 80–86.
  58. 58. Furman DP, Loomis EC (1984) The Ticks of California (Acari: Ixodida). Bulletin of the California Insect Survey, vol. 25. Berkeley: University of California Press. 247 p.
  59. 59. Crowder CD, Matthews HE, Schutzer S, Rounds MA, Luft BJ, et al. (2010) Genotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and Europe. PLoS One 5: e10650.
  60. 60. Tokarz R, Jain K, Bennett A, Briese T, Lipkin WI (2010) Assessment of polymicrobial infections in ticks in New York State. Vector Borne Zoonotic Dis 10: 217–221.
  61. 61. Dibernardo A, Cote T, Ogden NH, Lindsay LR (2014) The prevalence of Borrelia miyamotoi infection, and co-infections with other Borrelia spp. in Ixodes scapularis ticks collected in Canada. Parasites & Vectors 7: 183–190.